Subgroup analysis of the phase 2 MCL-002 (SPRINT) trial of lenalidomide in relapsed/refractory mantle cell lymphoma | Prof Marek Trněný at EHA 2015

At the 20th Congress of the European Hematology Association (EHA), Marek Trněný, MD, PhD, of Charles University, Prague, Czech Republic, discusses the results of the subgroup analysis of the phase 2 m... Author: EMJ Added: 06/29/2015
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts